Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens
- PMID: 20454614
- PMCID: PMC2864264
- DOI: 10.1371/journal.pntd.0000673
Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens
Abstract
Brucellosis is a widespread zoonotic disease that is also a potential agent of bioterrorism. Current serological assays to diagnose human brucellosis in clinical settings are based on detection of agglutinating anti-LPS antibodies. To better understand the universe of antibody responses that develop after B. melitensis infection, a protein microarray was fabricated containing 1,406 predicted B. melitensis proteins. The array was probed with sera from experimentally infected goats and naturally infected humans from an endemic region in Peru. The assay identified 18 antigens differentially recognized by infected and non-infected goats, and 13 serodiagnostic antigens that differentiate human patients proven to have acute brucellosis from syndromically similar patients. There were 31 cross-reactive antigens in healthy goats and 20 cross-reactive antigens in healthy humans. Only two of the serodiagnostic antigens and eight of the cross-reactive antigens overlap between humans and goats. Based on these results, a nitrocellulose line blot containing the human serodiagnostic antigens was fabricated and applied in a simple assay that validated the accuracy of the protein microarray results in the diagnosis of humans. These data demonstrate that an experimentally infected natural reservoir host produces a fundamentally different immune response than a naturally infected accidental human host.
Conflict of interest statement
PLF is an inventor on patent applications pertaining to this work and owns stock in a company (Anitigen Discovery Inc.) that has licensed the technology. XL is an inventor on patent applications pertaining to this work and is employed at a company (Anitigen Discovery Inc.) that has licensed the technology. WJWM is employed at company (Anitigen Discovery Inc.) that has licensed technology pertaining to this work.
Figures






References
-
- Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005;352:2325–2336. - PubMed
-
- Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV. The new global map of human brucellosis. Lancet Infect Dis. 2006;6:91–99. - PubMed
-
- Franco MP, Mulder M, Gilman RH, Smits HL. Human brucellosis. Lancet Infect Dis. 2007;7:775–786. - PubMed
-
- Young EJ. An overview of human brucellosis. Clin Infect Dis. 1995;21:283–289; quiz 290. - PubMed
-
- World Organisation for Animal Health. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals; 2009.